Internal Dashboards Corpus Appeals Corpus Wayback Coverage

WAYBACK COVERAGE MATRIX

96 cells (12 treatments × 8 payers) probed for archival viability via CDX with distinct-digest collapse, 2020-01-01 → 2025-12-31. Viable = ≥3 distinct calendar years. Determines what's reachable for cross-payer temporal corpus build.
96 CELLS 31 VIABLE ANTHEM/BSCA 0
Summary
Viable Cells
31 / 96
32% — ≥3 distinct years
Aetna
10 / 12
Best documented. PHP/IOP only gaps.
Magellan
8 / 12
Single MCG PDF — uniform across cells
Anthem
0 / 12
CDN paths never crawled. Significant gap.
BSCA
0 / 12
Wayback indexing essentially absent
Probe Date
2026-05-20
CDX, statuscode=200
Coverage Matrix (Treatment × Payer)

Cell shows distinct-years count. Green = viable (≥3 years). Yellow = 1–2 years (sub-viable). Gray = no captures / no URL.

Loading matrix…
Treatment Coverage Ranking
TreatmentViable / 8Note
TMS5Aetna, Cigna, UHC, Premera, Magellan — strongest
ABA5Heavily documented via state autism mandates
Esketamine5Strong corpus given drug only launched 2019
ECT3Aetna + Magellan dominant
Ketamine3Aetna, UHC (shared esketamine doc), Magellan
RTC3Aetna + Magellan MCG
Eating disorder residential2Aetna CPB 0511 + Magellan MCG
Psych testing2Aetna + Magellan
MAT / SUD2Aetna XR-bup CPB + Magellan
PHP, IOP1 eachMagellan only. Most payers fold into MNC/LOCG.
LAI antipsychotic1Aetna CPB 0020 (generic injectables) only
Structural Gaps
Generated 2026-05-20 · Source: stratum-corpus-data · analyses/wayback_coverage_*
← Appeals Corpus